Archives: Vidéos

SubLiminal Laser Therapy: Concept and reasons

30/09/2021
Dr Kenneth FONG presents SubLiminal Laser Therapy for macula diseases through the concepts and reasons, during APAO 2021

Macular Laser photocoagulation: Still relevant in 2021?

30/09/2021
During the EURETINA symposium, Dr Victor Chong explains his ideas on Macular Laser Photocoagulation wondering if it is still relevant in 2021.

Anti-VEGF vs Laser for PDR, a changing treatment paradigm?

30/09/2021
Dr Lihteh Wu talks about the controversies in laser treatment in 2021 during the EURETINA symposium.
Do We Still Need Subthreshold Laser for Macular Diseases?

Do We Still Need Subthreshold Laser for Macular Diseases?

25/06/2021
On the occasion of the launch of the new society SOLS (Subthreshold Ophthalmic Laser Society), Dr. Kenneth Fong, Dr. Victor Chong, Dr. Lihteh Wu, Dr Jay Chhablani & Dr. Alejandro Filloy Rius discussed the use of Subthreshold Laser for Macular Diseases.
What is the role of Easyret subthreshold laser in macular diseases?

What is the role of Easyret subthreshold laser in macular diseases?

07/06/2021
Dr Kenneth Fong reviews the role of Easyret® subthreshold laser for DME and CSR treatment. In this webinar (in English), he concludes that yellow subthreshold laser has more beneficial effect in visual acuity than half dose PDT.
Subliminal laser for AMD

SubLiminal laser for AMD

06/10/2020
Dr. Victor Chong presents the value of subliminal laser technology in the treatment of AMD.
SubLiminal Laser for predominantly non-center involving DME?

SubLiminal Laser for predominantly non-center involving DME?

06/10/2020
During EURETINA 2020, Dr Chritine Kiire presents Subliminal laser for predominantly non-centre involving Diabetic Macular Oedema.
Transfoveal subliminal laser treatment of CSCR

Transfoveal SubLiminal Laser treatment for CSC

06/10/2020
During EURETINA 2020, Dr Maciej Gawecki explained the role of Subliminal laser treatment for CSC.
Expanding clinical application of SubLiminal laser therapy

Concept and reasons of the SubLiminal laser approach: should we treat the fovea?

06/10/2020
During EURETINA 2020, Dr Lihteh Wu presents the concept and reasons of the SubLiminal laser approach: should we treat the fovea?
How to optimize retina laser treatments in 2020?

How to optimize retina laser treatments in 2020?

24/07/2020
Dr Kenneth Fong explains how to optimize retina laser treatments in 2020, in the COVID-19 era.

by

Quantel Medical & Ellex, 2 brands of Lumibird Medical, united with 1 objective: develop cutting-edge technologies for the diagnosis and treatment of dry eye and leading causes of blindness worldwide: glaucoma, cataracts, AMD and diabetic retinopathy.

Newsletter

"*" indicates required fields

Name
The information collected through this form is recorded and transmitted to the relevant QUANTEL MEDICAL departments and enables us to send you any reply to a request via the contact form. The legal basis for the processing is consent. The data collected are kept for 3 years in digital format and are only transmitted to QUANTEL MEDICAL’s internal departments as well as to our distributors and subsidiaries. You have a right to access, rectify, contest, limit the processing of and erase data. For more information on the use of your data and your rights resulting from the amended French Data Protection Act and the GDPR, please consult our data protection policy or contact our Data Protection Officer at rgpd@quantelmedical.fr.
Country*
Personal data compliance
For more informations on how Quantel Medical uses your data, please see our Terms and conditions.
© 2022 Quantel Medical
Share on email
Share this page by email
Share on facebook
Share this page on facebook
Share on twitter
Share this page on twitter
Share on linkedin
Share this page on linkedin